Michelle Yanez insider trades

Open-market stock purchases and sales by Michelle Yanez, Director at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since May 5, 2023.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • INTI Inhibitor Therapeutics, Inc: other filings, last Apr 1, 2025
  • MIRA Mira Pharmaceuticals, Inc: other filings, last Dec 9, 2024
  • TELO Telomir Pharmaceuticals, Inc: other filings, last Aug 27, 2024

Get free alerts when Michelle Yanez files a new trade →